Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-03-06 Purchase |
2024-03-08 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Duane Jon R Director |
6,920 | $8.7 | $60,204 | 121,028 (Direct) |
View |
2024-03-04 Purchase |
2024-03-06 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
10,684 | $9.38 | $100,216 | 301,733 (Direct) |
View |
2024-02-12 Sale |
2024-02-14 9:01 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer |
47,380 | $15.24 | $722,071 | 306,437 (Direct) |
View |
2024-02-12 Sale |
2024-02-14 8:53 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug |
38,618 | $15.24 | $588,538 | 422,125 (Direct) |
View |
2024-02-12 Sale |
2024-02-14 8:50 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Silver Ronald Principal Accounting Officer |
7,908 | $15.24 | $120,518 | 161,477 (Direct) |
View |
2024-02-12 Sale |
2024-02-14 8:42 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
9,846 | $15.24 | $150,053 | 306,292 (Direct) |
View |
2024-02-12 Sale |
2024-02-14 8:35 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer |
177,164 | $15.24 | $2,699,979 | 832,774 (Direct) |
View |
2023-12-14 Sale |
2023-12-18 4:09 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Kessler Marla L Director |
9,926 | $11.19 | $111,072 | 96,572 (Direct) |
View |
2023-11-20 Sale |
2023-11-22 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
3,287 | $9.69 | $31,851 | 217,374 (Direct) |
View |
2023-09-15 Purchase |
2023-09-18 5:07 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
36,072 | $8.32 | $300,119 | 188,730 (Direct) |
View |
2023-08-14 Sale |
2023-08-16 4:21 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Silver Ronald Principal Accounting Officer |
1,976 | $10.04 | $19,839 | 134,172 (Direct) |
View |
2023-08-14 Sale |
2023-08-16 4:20 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer |
7,045 | $10.04 | $70,732 | 192,195 (Direct) |
View |
2023-05-30 Sale |
2023-06-01 5:45 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer |
26,632 | $10.7 | $284,962 | 758,284 (Direct) |
View |
2023-05-22 Sale |
2023-05-24 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug |
10,324 | $10.12 | $104,479 | 321,131 (Direct) |
View |
2023-05-22 Sale |
2023-05-24 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
6,305 | $10.12 | $63,807 | 219,327 (Direct) |
View |
2023-05-22 Sale |
2023-05-24 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer |
36,000 | $10.12 | $364,320 | 784,916 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-03-08 Exercise |
2024-03-12 4:05 pm |
N/A 2026-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer |
120,298 | $0 | 1,217,948 (Direct) |
View |
2024-03-05 Option Award |
2024-03-07 4:05 pm |
N/A 2027-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer |
397,314 | $0 | 1,230,088 (Direct) |
View |
2024-02-12 Option Award |
2024-02-14 9:01 pm |
N/A 2027-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer |
81,641 | $0 | 306,437 (Direct) |
View |
2024-02-12 Option Award |
2024-02-14 8:53 pm |
N/A 2027-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug |
81,641 | $0 | 422,125 (Direct) |
View |
2024-02-12 Option Award |
2024-02-14 8:50 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Silver Ronald Principal Accounting Officer |
27,213 | $0 | 161,477 (Direct) |
View |
2024-02-12 Option Award |
2024-02-14 8:42 pm |
N/A 2027-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
97,968 | $0 | 306,292 (Direct) |
View |
2024-02-12 Option Award |
2024-02-14 8:39 pm |
N/A 2027-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
97,968 | $0 | 323,705 (Direct) |
View |
2024-02-08 Tax Withholding |
2024-02-12 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
41,332 | $14.9 | 225,737 (Direct) |
View |
2024-01-17 Option Award |
2024-01-19 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer |
249,617 | $0 | 1,009,938 (Direct) |
View |
2024-01-17 Option Award |
2024-01-19 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug |
57,971 | $0 | 379,102 (Direct) |
View |
2024-01-17 Option Award |
2024-01-19 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer |
79,981 | $0 | 272,176 (Direct) |
View |
2024-01-17 Option Award |
2024-01-19 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
85,000 | $0 | 267,069 (Direct) |
View |
2023-12-15 Option Award |
2023-12-19 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner |
1,347 | $0 | 16,510,277 (Direct) |
View |
2023-12-15 Option Award |
2023-12-19 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Moukheibir Catherine Director |
1,572 | $0 | 128,633 (Direct) |
View |
2023-11-16 Tax Withholding |
2023-11-20 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
6,661 | $9.44 | 182,069 (Direct) |
View |
2023-09-15 Option Award |
2023-09-19 5:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Moukheibir Catherine Director |
2,098 | $0 | 127,061 (Direct) |
View |
2023-09-15 Option Award |
2023-09-19 5:04 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner |
1,798 | $0 | 16,508,930 (Direct) |
View |
2023-08-29 Option Award |
2023-08-31 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Silver Ronald Principal Accounting Officer |
8,000 | $0 | 142,172 (Direct) |
View |
2023-06-20 Option Award |
2023-06-22 5:31 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Shepard Jay Director |
22,350 | $0 | 102,244 (Direct) |
View |
2023-06-20 Option Award |
2023-06-22 5:30 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Moukheibir Catherine Director |
22,350 | $0 | 124,963 (Direct) |
View |
2023-06-20 Option Award |
2023-06-22 5:29 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | McHugh Julie Director |
22,350 | $0 | 162,294 (Direct) |
View |
2023-06-20 Option Award |
2023-06-22 5:29 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Kessler Marla L Director |
22,350 | $0 | 106,498 (Direct) |
View |
2023-06-20 Option Award |
2023-06-22 5:28 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Duane Jon R Director |
22,350 | $0 | 114,108 (Direct) |
View |
2023-06-20 Option Award |
2023-06-22 5:27 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Dreyfus Andrew Director |
22,350 | $0 | 168,980 (Direct) |
View |
2023-06-20 Option Award |
2023-06-22 5:26 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner |
22,350 | $0 | 16,507,132 (Direct) |
View |
2023-06-20 Option Award |
2023-06-22 5:26 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Currie Mark G Director |
22,350 | $0 | 544,108 (Direct) |
View |
2023-06-15 Option Award |
2023-06-20 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Moukheibir Catherine Director |
1,586 | $0 | 102,613 (Direct) |
View |
2023-06-15 Option Award |
2023-06-20 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner |
1,359 | $0 | 16,484,782 (Direct) |
View |